跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
捷诺维 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Sitagliptin Phosphate Tablets
Approved
化学药品
Sitagliptin Phosphate Tablets
Merck Sharp & Dohme BV
🇨🇳 National Medical Products Administration
Approval Date
May 5, 2023
Approval ID
1z32ZkdpR6A
Company
Merck Sharp & Dohme BV
Type
化学药品
Approval Details
Approval Id
1z32ZkdpR6A
Approval Number
国药准字HJ20140153
Generic Name
磷酸西格列汀片
Generic Name En
Sitagliptin Phosphate Tablets
Trade Name
捷诺维
Drug Type
化学药品
Dosage Form
片剂
Strength
100mg
Reg Date
2023-05-05
Expired Date
2028-05-04
Company Name
Merck Sharp & Dohme BV
Production Company Name
ORGANON PHARMA (UK) LIMITED
Company Detail Path
/organization/merck-sharp-and-dohme-bv
Production Company Detail Path
/organization/organon-pharma-uk-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 5, 2023
Approval ID
1z32ZkdpR6A
Type
化学药品
Back to NMPA Approvals